Effect of acupuncture or moxibustion at Acupoints Weizhong (BL40) or Chize (LU5) on the change in lumbar temperature in healthy adults: A study protocol for a randomized controlled trial with a 2 × 2 factorial design
PLOS ONE · 2023
DOI: 10.1371/journal.pone.0291536 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift PLOS ONE, 2023. Verfasst von Siyi Zheng und 10 weiteren Autor:innen. Beteiligte Einrichtung: The Third School of Clinical Medicine, Zhejiang Chinese Medical University, Hangzhou, China. Hauptthemen laut MEDLINE: Moxibustion, Acupuncture Therapy. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 17 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key Research and Development Program of China.
Abstract (Originalsprache)
Background
Low back pain is a common complaint among adults, and moxibustion and acupuncture are commonly used treatments. In traditional theory, Weizhong (BL40) is a popular acupoint, as supported by the saying “Yao Bei Wei Zhong Qiu.” However, the difference in efficacy between acupuncture and moxibustion remains unclear. Therefore, this trial will compare the thermal effects of acupuncture and moxibustion at BL40 and Chize point (LU5) in healthy adults to provide more objective evidence regarding the relationship between the lumbar and BL40. Method/Design The trial will use a two-by-two factorial design, randomly assigning 140 participants to four groups (acupuncture at Weizhong (BL40), acupuncture at Chize (LU5), moxibustion at Weizhong (BL40), and moxibustion at Chize (LU5)) at a ratio of 1:1:1:1. Each group will undergo a 30-minute intervention, with the primary outcome being mean temperature in the lumbar region at the last minute of the intervention period. Secondary outcomes include maximum lumbar temperature in the lumbar region at the last minute of the intervention, average lumbar temperature and average bladder meridian temperature at specific time points during and after the intervention, and scores on the warming sensation questionnaire. Data will be analyzed on an intention-to-treat basis.
Discussion
This study will be the first to compare the thermal effect difference in the lumbar area between acupuncture and moxibustion in healthy individuals. The findings of this study will provide new insights for the "Yao Bei Wei Zhong Qiu" theory of traditional Chinese medicine.
Trial registration
ClinicalTrials.gov, Trial number: NCT05665426 . Registered on 26 December 2022.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- The Third School of Clinical Medicine, Zhejiang Chinese Medical University, Hangzhou, China.
- Department of Acupuncture and Moxibustion, The Third Affiliated Hospital of Zhejiang Chinese Medical University (Zhongshan Hospital of Zhejiang Province), Hangzhou, China.
ORCID-Profile: Siyi Zheng, Yi Liang
Förderung
- National Key Research and Development Program of China
Zitieren
APA
Zheng, S., Shen, Q., Lyu, Z., Tian, S., Huang, X., Liu, Y., Yu, X., Pan, W., Nie, N., Liang, Y., & Fang, J. (2023). Effect of acupuncture or moxibustion at Acupoints Weizhong (BL40) or Chize (LU5) on the change in lumbar temperature in healthy adults: A study protocol for a randomized controlled trial with a 2 × 2 factorial design. PLOS ONE. https://doi.org/10.1371/journal.pone.0291536
Vancouver
Zheng S, Shen Q, Lyu Z, Tian S, Huang X, Liu Y, et al. Effect of acupuncture or moxibustion at Acupoints Weizhong (BL40) or Chize (LU5) on the change in lumbar temperature in healthy adults: A study protocol for a randomized controlled trial with a 2 × 2 factorial design. PLOS ONE. 2023. doi:10.1371/journal.pone.0291536
BibTeX
@article{Zheng2023,
author = {Zheng, Siyi and Shen, Qiongying and Lyu, Zhengyi and Tian, Shuxin and Huang, Xiaoxiao and Liu, Yiyue and Yu, Xiaoshuai and Pan, Wei and Nie, Na and Liang, Yi and Fang, Jianqiao},
title = {Effect of acupuncture or moxibustion at Acupoints Weizhong (BL40) or Chize (LU5) on the change in lumbar temperature in healthy adults: A study protocol for a randomized controlled trial with a 2 × 2 factorial design},
journal = {PLOS ONE},
year = {2023},
doi = {10.1371/journal.pone.0291536}
}
EUVIMED